Giles R - Search Results

1

Expression of pre-selected TMEMs with predicted ER localization as potential classifiers of ccRCC tumors.

Wrzesiński T, Szelag M, Cieślikowski WA, Ida A, Giles R, Zodro E, Szumska J, Poźniak J, Kwias Z, Bluyssen HA, Wesoly J. Wrzesiński T, et al. Among authors: giles r. BMC Cancer. 2015 Jul 14;15:518. doi: 10.1186/s12885-015-1530-4. BMC Cancer. 2015. PMID: 26169495 Free PMC article.

2

Fibronectin is a hypoxia-independent target of the tumor suppressor VHL.

Bluyssen HA, Lolkema MP, van Beest M, Boone M, Snijckers CM, Los M, Gebbink MF, Braam B, Holstege FC, Giles RH, Voest EE. Bluyssen HA, et al. Among authors: giles rh. FEBS Lett. 2004 Jan 2;556(1-3):137-42. doi: 10.1016/s0014-5793(03)01392-9. FEBS Lett. 2004. PMID: 14706840 Free article.

3

Regulation of E2F1 by the von Hippel-Lindau tumour suppressor protein predicts survival in renal cell cancer patients.

Mans DA, Vermaat JS, Weijts BG, van Rooijen E, van Reeuwijk J, Boldt K, Daenen LG, van der Groep P, Rowland BD, Jans JJ, Roepman R, Voest EE, van Diest PJ, Verhaar MC, de Bruin A, Giles RH. Mans DA, et al. Among authors: giles rh. J Pathol. 2013 Sep;231(1):117-29. doi: 10.1002/path.4219. J Pathol. 2013. PMID: 23744542

4

Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma.

Groenewegen G, Walraven M, Vermaat J, de Gast B, Witteveen E, Giles R, Haanen J, Voest E. Groenewegen G, et al. Among authors: giles r. Br J Cancer. 2012 Jan 17;106(2):284-9. doi: 10.1038/bjc.2011.515. Epub 2012 Jan 3. Br J Cancer. 2012. PMID: 22215065 Free PMC article. Clinical Trial.

5

Circulating mitochondrial nucleic acids have prognostic value for survival in patients with advanced prostate cancer.

Mehra N, Penning M, Maas J, van Daal N, Giles RH, Voest EE. Mehra N, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):421-6. doi: 10.1158/1078-0432.CCR-06-1087. Clin Cancer Res. 2007. PMID: 17255261

6

Allele-specific regulation of primary cilia function by the von Hippel-Lindau tumor suppressor.

Lolkema MP, Mans DA, Ulfman LH, Volpi S, Voest EE, Giles RH. Lolkema MP, et al. Eur J Hum Genet. 2008 Jan;16(1):73-8. doi: 10.1038/sj.ejhg.5201930. Epub 2007 Oct 3. Eur J Hum Genet. 2008. PMID: 17912253

7

Clear cell chondrosarcoma in Von Hippel-Lindau disease.

Dreijerink KMA, van Leeuwaarde RS, Hackeng WM, Giles RH, de Leng WWJ, Jutte PC, Suurmeijer AJH, van Nesselrooij BPM, Brosens LAA. Dreijerink KMA, et al. Fam Cancer. 2020 Jan;19(1):41-45. doi: 10.1007/s10689-019-00149-1. Fam Cancer. 2020. PMID: 31673890 Free PMC article.

8

Progenitor marker CD133 mRNA is elevated in peripheral blood of cancer patients with bone metastases.

Mehra N, Penning M, Maas J, Beerepoot LV, van Daal N, van Gils CH, Giles RH, Voest EE. Mehra N, et al. Clin Cancer Res. 2006 Aug 15;12(16):4859-66. doi: 10.1158/1078-0432.CCR-06-0422. Clin Cancer Res. 2006. PMID: 16914572

9

Control of Angiogenesis via a VHL/miR-212/132 Axis.

Lei Z, Klasson TD, Brandt MM, van de Hoek G, Logister I, Cheng C, Doevendans PA, Sluijter JPG, Giles RH. Lei Z, et al. Cells. 2020 Apr 19;9(4):1017. doi: 10.3390/cells9041017. Cells. 2020. PMID: 32325871 Free PMC article.

10

The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell periphery.

Lolkema MP, Mehra N, Jorna AS, van Beest M, Giles RH, Voest EE. Lolkema MP, et al. Exp Cell Res. 2004 Dec 10;301(2):139-46. doi: 10.1016/j.yexcr.2004.07.016. Exp Cell Res. 2004. PMID: 15530850

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters